Details for New Drug Application (NDA): 017667
✉ Email this page to a colleague
NDA 017667 describes MPI STANNOUS DIPHOSPHONATE, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the MPI STANNOUS DIPHOSPHONATE profile page.
The generic ingredient in MPI STANNOUS DIPHOSPHONATE is technetium tc-99m etidronate kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m etidronate kit profile page.
The generic ingredient in MPI STANNOUS DIPHOSPHONATE is technetium tc-99m etidronate kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m etidronate kit profile page.
Summary for 017667
| Tradename: | MPI STANNOUS DIPHOSPHONATE |
| Applicant: | Ge Healthcare |
| Ingredient: | technetium tc-99m etidronate kit |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | N/A | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
